Delivery Order SPE2DB20D3103-SPE2DB25FP1H8
Award Date 6/11/25
Potential Completion Date 7/3/25
Potential Value $88K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $131,429.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 mL vials. This contract, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $52,571.70 to AmerisourceBergen Drug Corp for the supply of Ultomiris (1,100 mg/11 mL vial), a pharmaceutical product for military healthcare needs. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 6, 2025, performed from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $50,978.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 ml vials. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a continuation of the company's...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $102,754.09 for Ultomiris 300 mg/3 mL vials on September 15, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is scheduled for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $23,896.30 by the Defense Logistics Agency (DLA) for the supply of Ultomiris 300 mg/3 ml vials. The contract, awarded on September 12, 2025, carries an ultimate completion date of October 3, 2025, and represents a non-set-aside competitive award. As a child order under a larger contract vehicle, this delivery order fulfills DLA's medical supply procurement...
- The Defense Logistics Agency awarded a $9,558.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ultomiris 300 mg/3 ml vials. This non-competitive delivery order, with an ultimate completion date of September 29, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 6, 2025, for the supply of Ultomiris (periphakin alfa) 1,100 mg/11 ml vials under a firm fixed-price contract. The award, valued at $26,285.85 with a completion date of June 30, 2025, represents a non-competitive, non-set-aside delivery order issued by the Defense Logistics Agency's Medical Supply Chain. This contract is a child award under...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,420.20 for Ultomiris 300 mg/3 ml vials on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price, competitively awarded contract (No. 4569318413) is being funded by the Defense Logistics Agency's Medical Supply Chain, a Defense Department entity responsible for pharmaceutical and medical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,285.85 for 1,100 mg/11 mL vials of Ultomiris, a complement inhibitor medication used to treat rare blood disorders and other conditions. This firm fixed-price, non-competitive set-aside contract was awarded on August 14, 2025, with an ultimate completion date of September 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This delivery order, valued at $52,571.70 and awarded on September 19, 2025, provides Ultomiris (pegcetacoplan) 1,100 mg/11 mL vials to support federal medical procurement needs. The contract is a firm fixed price delivery order issued under a competitive, non-set-aside procurement process to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will be executed at the contractor's corporate office location in Conshohocken,...